Camp4 Therapeutics Corporation (CAMP)

NASDAQ: CAMP · Real-Time Price · USD

1.650

-0.020 (-1.20%)

At close: Jul 30, 2025, 4:00 PM

1.570

-0.080 (-4.85%)

Pre-market: Jul 31, 2025, 8:04 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Regulatory Ribonucleic Acid-based Therapeutics	350.00K

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
United States	350.00K